出生时接种卡介苗(BCG)与儿童期疫苗抗体应答:一项随机临床试验
在丹麦卡介苗研究(Danish Calmette Study)的随机临床试验中,300名儿童(178名BCG组,122名对照组)出生后7天内随机接种BCG或不干预,于3、5、12月龄接种三剂DiTeKiPol/Act-Hib和Prevenar 13后4周检测抗体。几乎所有儿童(>96%)抗体应答超过保护水平,BCG接种总体不影响抗体水平;按随机化日龄分层,出生首日后接种BCG可能诱导针对百日咳杆菌和所有肺炎球菌血清型的抗体;女孩针对b型流感嗜血杆菌和肺炎球菌的抗体水平显著高于男孩。
要点
- 300名儿童中>96%在常规三剂疫苗接种后抗体达保护水平。
- 出生时接种BCG总体不改变对DiTeKiPol/Act-Hib和Prevenar 13的抗体应答。
- 首日后接种BCG可能诱导针对百日咳杆菌和所有肺炎球菌血清型的抗体。
核心结论
- 三剂常规DiTeKiPol/Act-Hib和Prevenar 13接种使几乎所有儿童产生血清保护水平抗体,出生时BCG接种未见总体效果。
研究设计与样本
- 在丹麦卡介苗研究(Danish Calmette Study)随机临床试验内,将出生后7天内的儿童1:1随机分为BCG接种组或对照组(不干预),对部分参与者检测抗体。
主要发现
- 300名纳入儿童中178名接种BCG、122名对照,几乎所有儿童(>96%)抗体应答超过保护水平。
- 出生时BCG接种总体不影响抗体水平;按随机化日龄分层,出生首日后接种BCG可能诱导针对百日咳杆菌和所有肺炎球菌血清型的抗体。
- 女孩针对b型流感嗜血杆菌和肺炎球菌的抗体水平显著高于男孩。
关键数值与推荐
- 在3、5、12月龄接种三剂DiTeKiPol/Act-Hib和Prevenar 13后4周检测针对肺炎球菌血清型4、6B、9V、14、18C、19F和23F的抗体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: BCG vaccination has been associated with beneficial non-specific effects on child health. Some immunological studies have reported heterologous effects of vaccines on antibody responses to heterologous vaccines. Within a randomised clinical trial of Bacille Calmette-Guérin (BCG) vaccination at birth, The Danish Calmette Study, we investigated the effect of BCG at birth on the antibody response to the three routine vaccines against DiTeKiPol/Act-Hib and Prevenar 13 in a subgroup of participants. METHODS: Within 7days after birth, children were randomised 1:1 to BCG vaccination or to the control group (no intervention). After three routine vaccinations given at age 3, 5 and 12months, antibodies against DiTeKiPol/Act-Hib and Prevenar 13 (Streptococcus pneumoniae serotype type 4, 6B, 9V, 14, 18C, 19F and 23F) were measured 4weeks after the third vaccine dose. RESULTS: Among the 300 included children (178 BCG; 122 controls), almost all children (>96%) had antibody responses above the protective levels. Overall BCG vaccination at birth did not affect the antibody level. When stratifying by 'age at randomisation' we found a possible inducing effect of BCG on antibodies against B. pertussis and all pneumococcal serotypes, when BCG was given after the first day of life. Girls had significantly higher antibody levels for Haemophilus influenza type b and pneumococcus than boys. CONCLUSIONS AND RELEVANCE: Three routine vaccinations with DiTeKiPol/Act-Hib and Prevenar 13 induced sero-protective levels in almost all children. No overall effect of neonatal BCG vaccination was observed.
引用
- Nissen TN, Birk NM, Smits G, et al. Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial. Vaccine. 2017. PMID: 28318766. doi:10.1016/j.vaccine.2017.02.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。